Viemed Healthcare VMD Estimates

NASDAQ VMD
$8.61 -0.18 (-1.99%)
As of: Sep 9, 2026 · 1:41 PM EDT
Analyst Estimates

Viemed Healthcare, Inc. Revenue Estimates

Periods 22
Next Period Q3 26
Consensus 82.83 M

Analysts expect Viemed Healthcare, Inc. to report revenue of 82.83 M for Q3 26, against a range of 78.89 M to 86.77 M. The most recent reported quarter, Q2 26, came in at 78.10 M, a 4.5% beat against the 74.77 M consensus.

Metric Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29
Reported (Actual) 58.00 M60.70 M59.10 M63.10 M71.91 M76.18 M75.41 M78.10 M--------
High Estimate 58.92 M64.30 M65.08 M72.03 M80.50 M78.03 M82.70 M79.97 M86.77 M83.93 M84.14 M94.47 M101.72 M93.86 M95.23 M111.83 M
Low Estimate 51.69 M58.38 M58.65 M60.12 M67.59 M72.23 M70.33 M69.57 M78.89 M75.53 M72.35 M82.30 M93.75 M87.32 M80.44 M92.74 M
Consensus Estimate 55.30 M61.34 M61.87 M66.08 M74.04 M75.13 M76.52 M74.77 M82.83 M79.73 M78.24 M88.38 M97.73 M90.59 M87.84 M102.29 M
Analyst Estimates

Viemed Healthcare, Inc. Earnings Per Share (EPS) Estimates

Periods 22
Next Period Q3 26
Consensus 0.11

Analysts expect Viemed Healthcare, Inc. to report earnings per share of 0.11 for Q3 26, against a range of 0.10 to 0.12. The most recent reported quarter, Q2 26, came in at 0.07, a 41.7% miss against the 0.12 consensus.

Metric Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29
Reported (Actual) 0.100.100.060.080.090.140.060.07--------
High Estimate 0.070.120.060.100.100.120.100.130.120.160.110.150.180.200.110.16
Low Estimate 0.070.100.060.080.080.120.080.110.100.140.090.130.160.180.090.14
Consensus Estimate 0.070.110.060.090.090.120.090.120.110.150.100.140.170.190.100.15